and colonic IgA in type 1 diabetes could be further investigated by, for example, including faecal IgA assays and sorting strategies that identify gut bacterial IgA coating in current and upcoming type 1 diabetes cohort studies. This evidence concerns the gene CD79A and type 1 diabetes mellitus.